Self-Accelerated Nanoregulators for Positive Feedback Ferroptosis-Immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Immunotherapy

Background:

• Conventional nanomedicines struggle with specificity and sensitivity in the tumor microenvironment, leading to adverse effects and limited efficacy.
• The immunosuppressive tumor microenvironment hinders effective cancer treatment.
• Developing intelligent drug delivery systems is crucial for overcoming these challenges.

Purpose of the Study:

• To develop a cascade-responsive multi-polyprodrug nanoregulator for enhanced tumor therapy.
• To achieve synergistic anti-tumor effects by combining chemotherapy, ferroptosis, and apoptosis.
• To overcome the immunosuppressive tumor microenvironment and activate anti-tumor immunity.

Main Methods:

• A novel nanoregulator was designed to release doxorubicin, 1-methyl-tryptophan, and cinnamaldehyde in a self-accelerating manner.
• The nanoregulator responds to the high hydrogen peroxide levels in the tumor microenvironment.
• The study investigated the combined effects of reactive oxygen species-induced ferroptosis and doxorubicin-induced apoptosis.

Main Results:

• The nanoregulator effectively induced immunogenic cell death and activated the immune response.
• 1-methyl-tryptophan promoted cytotoxic T lymphocyte activation and reduced immune escape.
• A positive feedback loop between ferroptosis and immunotherapy was established, enhancing treatment efficacy.

Conclusions:

• The developed nanoregulator offers a self-accelerated drug delivery strategy for synergistic tumor immunotherapy.
• Combining ferroptosis and apoptosis presents a promising approach for overcoming tumor immunosuppression.
• This work provides a potential cooperation mode for advanced cancer treatment strategies.